You have 9 free searches left this month | to do more

abemaciclib

Abemaciclib is a drug used to treat Breast Cancer, Advanced Cancer, Metastatic Breast Carcinoma, and other conditions. Abemaciclib is being actively studied in 89 studies and prior, has been studied in 18.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterZahi Mitri, MD, MS
Dana-Farber Cancer InstituteFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Anita Turk
National Cancer Institute (NCI)Dana Farber Cancer InstituteAtish Choudhury
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Not yet recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-10-01
Oct 1, 2021
S
Not yet recruiting
  • Advanced Dedifferentiated Liposarcoma
  • Abemaciclib
  • Placebo
  • (no location specified)
2021-07-23
Jul 23, 2021
M
Active, not recruiting
  • Sarcoma
  • Dedifferentiated Liposarcoma
  • Abemaciclib
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-08-17
Aug 17, 2021
D
Active, not recruiting
  • Breast Cancer
  • Abemaciclib
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-10-12
Oct 12, 2021
D
Suspended
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
2021-08-13
Aug 13, 2021
D
Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-09-20
Sep 20, 2021
S
Recruiting
  • Thyroid Cancer
  • +2 more
  • Abemaciclib
  • Stanford, California
    Stanford University
2021-04-28
Apr 28, 2021
U
Recruiting
  • HNSCC
  • Abemaciclib
  • Tucson, Arizona
    University of Arizona
2021-09-03
Sep 3, 2021
A
Active, not recruiting
  • Hepatocellular Carcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-08-05
Aug 5, 2021
M
Recruiting
  • Solid Tumor
  • Advanced Breast Cancer
  • Abemaciclib
  • +6 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
2021-10-13
Oct 13, 2021
H
Recruiting
  • Breast Cancer
  • abemaciclib
  • Athens, Greece
    Hellenic Oncology Cooperative Group
2021-07-26
Jul 26, 2021
N
Recruiting
  • Neurofibromatosis 1
  • Abemaciclib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-07
Oct 7, 2021
N
Recruiting
  • Kaposi Sarcoma
  • Abemaciclib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-09-30
Sep 30, 2021
B
Not yet recruiting
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Dallas, Texas
    Baylor University Medical Center, Charles A Sammons Cancer Cente
2021-06-04
Jun 4, 2021
E
Completed
  • Advanced Cancer
  • Abemaciclib
  • +2 more
  • Kashiwa, Chiba, Japan
  • +1 more
2021-09-20
Sep 20, 2021
N
Recruiting
  • Endometrial Endometrioid Adenocarcinoma
  • Abemaciclib
  • +2 more
  • Chicago, Illinois
  • +1 more
2021-04-30
Apr 30, 2021
H
Recruiting
  • Brain Metastases
  • HR+ Metastatic Breast Cancer
  • Stereotactic Radiosurgery (SRS)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
2021-07-29
Jul 29, 2021
D
Withdrawn
  • Breast Cancer
  • (no location specified)
2020-10-21
Oct 21, 2020
D
Recruiting
  • Endometrial Cancer
  • Boston, Massachusetts
  • +2 more
2021-06-23
Jun 23, 2021
Z
Recruiting
  • Breast Cancer
  • Gilbert, Arizona
  • +3 more
2021-09-13
Sep 13, 2021
U
Recruiting
  • Breast Cancer
  • Dallas, Texas
  • +1 more
2021-09-09
Sep 9, 2021
E
Recruiting
  • GBM
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
2020-12-11
Dec 11, 2020
D
Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Abemaciclib
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
2021-07-08
Jul 8, 2021